HI SB 2933
died on adjournmentRELATING TO HEALTH CARE COSTS.
Hawaii · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did HI SB 2933 pass?
No. HI SB 2933 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-18): The committee on HHS deferred the measure.
What is HI SB 2933 about?
Establishes the Prescription Drug Affordability Board within the Department of Health to conduct affordability reviews on high-cost prescription drugs and establish upper payment limits under certain circumstances. Establishes out-of-pocket maximums for prescribed insulin, asthma inhalers, and epinephrine auto-injectors. Prohibits copayment adjustment programs. Requires health insurers, mutual benefit societies, and health maintenance organizations to comply with certain affordability measures. Requires annual reports to the Legislature. Requires adoption of rules by the Affordability Board and Insurance Commissioner. Appropriates funds.
Who sponsors HI SB 2933?
MCKELVEY, CHANG, HASHIMOTO and 1 others are the primary sponsors of HI SB 2933.
Description
Establishes the Prescription Drug Affordability Board within the Department of Health to conduct affordability reviews on high-cost prescription drugs and establish upper payment limits under certain circumstances. Establishes out-of-pocket maximums for prescribed insulin, asthma inhalers, and epinephrine auto-injectors. Prohibits copayment adjustment programs. Requires health insurers, mutual benefit societies, and health maintenance organizations to comply with certain affordability measures. Requires annual reports to the Legislature. Requires adoption of rules by the Affordability Board and Insurance Commissioner. Appropriates funds.
- Introduced
- 2026-01-23
- Latest action
- 2026-02-18 — The committee on HHS deferred the measure.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- MCKELVEYprimary
- CHANGprimary
- HASHIMOTOprimary
- KIDANIprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-02-18
The committee on HHS deferred the measure.
deferral
2026-02-18
The committee on CPN deferred the measure.
deferral
2026-02-17
The committee(s) on HHS/CPN deferred the measure until 02-18-26 10:06AM; Conference Room 229 & Videoconference.
deferral
2026-02-13
The committee(s) on HHS/CPN has scheduled a public hearing on 02-17-26 9:45AM; Conference Room 229 & Videoconference.
2026-01-30
Referred to HHS/CPN, WAM/JDC.
referral-committee
2026-01-26
Passed First Reading.
reading-1
2026-01-23
Introduced.
introduction
Versions
- SB2933Compare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:20:09.051962Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=HI&identifier=SB 2933. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.